[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"covid-19-lower-respiratory-infection\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:covid-19-lower-respiratory-infection":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":32,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100451918","cardiac-magnetic-resonance-tissue-characterization-in-covid-19-survivors-100451918",false,"NCT05164744","Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors","Cardiac Magnetic Resonance for Tissue Characterization-Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors","Inclusion Criteria:\n\n* Emergency room presentation and\u002For hospitalization with COVID-19 infection defined in accordance with established criteria as follows: SAR-CoV2 RT-PCR+ (severe acute respiratory syndrome coronavirus 2 reverse transcription polymerase chain reaction) and at least one of the following symptoms: dyspnea, cough, dysphagia, rhinorrhea, diarrhea, nausea\u002Fvomiting, myalgias, fever, syncope\u002Fpresyncope.\n\nExclusion criteria:\n\n* Contraindication to CMR (i.e. non-compatible pacemaker\u002Fdefibrillator) or gadolinium (known hypersensitivity, eGFR (estimated globular filtration rate) \\\u003C30 ml\u002Fmin\u002F1.73m2).\n* Inability to provide informed consent (e.g. cognitive impairment).\n* Unrelated condition (e.g. neoplasm) with life expectancy \\\u003C12 months prohibiting follow-up.\n* Patients with contraindications to gadolinium (known or suspected hypersensitivity, glomerular filtration rate \\\u003C 30 ml\u002Fmin\u002F1.73m2) will undergo non-contrast MRI but will not be excluded from this study.\n* Patients with known or suspected pregnancy based on Weill Cornell Radiology intake surveys (reviewed by a clinical RN (registered nurse), as well as research personnel) will be excluded from the protocol.",true,"ALL","18 Years",{"count":20,"type":21},510,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to test if visualizing the heart with cardiac MRI\u002Fecho will be important in the understanding cardiac function and prediction of cardiopulmonary symptoms, physical effort tolerance, and outcomes in COVID-19 survivors. If successful, the research will allow us to identify the causes of lasting cardiopulmonary symptoms and begin developing cardiac and lung directed therapies accordingly.",[25,26,27,28,29,30,31],"COVID-19 Pneumonia","COVID-19","COVID-19 Respiratory Infection","COVID-19 Acute Respiratory Distress Syndrome","COVID-19 Lower Respiratory Infection","COVID-19 Acute Bronchitis","Coronavirus Disease 2019",[33],"coronavirus disease 2019,","RECRUITING","2026-01-20",{"date":37,"type":38},"2026-01-22","ACTUAL",{"date":40,"type":38},"2021-07-01",{"date":42,"type":21},"2026-07-30",{"name":44,"class":45},"Weill Medical College of Cornell University","OTHER",3]